Completed

STOP-FALLS-DDeprescribing to Reduce Injurious Falls Among Older Adults With Dementia

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

STOP Falls D Educational Intervention

Behavioral
Who is being recruted

Mental Disorders+3

+ Brain Diseases

+ Central Nervous System Diseases

Over 18 Years
See all eligibility criteria
How is the trial designed

Services Research Study

Interventional
Study Start: February 2023
See protocol details

Summary

Principal SponsorUniversity of Washington
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: February 22, 2023

Actual date on which the first participant was enrolled.

The study design is a pragmatic, one-arm pilot trial to test the feasibility and acceptability of implementing a deprescribing intervention with older people with dementia and their care partners in primary care. The intervention consists of patient-facing educational brochures on CNS-active medications and decision support for the primary care provider. Ethnic/minority groups will be over-sampled to ensure a diverse study sample.

Official TitleDeprescribing to Reduce Injurious Falls Among Older Adults With Dementia
NCT05777772
Principal SponsorUniversity of Washington
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

123 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Services Research Study

These studies look at how healthcare is delivered, managed, and organized. They aim to improve care quality, patient experience, and access to treatment.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Mental DisordersBrain DiseasesCentral Nervous System DiseasesDementiaNervous System DiseasesNeurocognitive Disorders

Criteria

Older Adult Sample Inclusion Criteria: * Diagnosed dementia (dementia diagnosis code or prescription for dementia medication) * Receiving primary care at a Kaiser Permanente Washington integrated group practice outpatient clinic * Prescribed at least one CNS-active medication on a chronic (3 months or more) basis Exclusion Criteria: * Skilled nursing facility resident * Current cancer diagnosis * On hospice or palliative care Care Partner Sample Inclusion Criteria: * Aged 18 years or older * Self-identify as a care partner for the older adult with dementia

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Educational Intervention

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Kaiser Permanente Health Research Institute

Seattle, United StatesOpen Kaiser Permanente Health Research Institute in Google Maps
CompletedOne Study Center